Maturity-onset diabetes of the young (MODY) as a result of mutations in hepatocyte nuclear factor 1-alpha (hs-CRP levels were assessed in 750 patients (220hs-CRP was lower in HNF1A-MODY (median [IQR] 0.3 [0.1-0.6] mg/L) than type 2 diabetes (1.40 [0.60-3.45] mg/L;hs-CRP levels are lower in HNF1A-MODY than other forms of diabetes and may be used as a biomarker to select patients for diagnostic